• Profile
Close

Association of 2-year progression along the AREDS AMD scale and development of late age-related macular degeneration or loss of visual acuity AREDS report 41

JAMA Ophthalmology Jun 27, 2020

Vitale S, Agrón E, Clemons TE, et al. - Researchers investigated if the risk of late age-related macular degeneration or loss of visual acuity could be estimated using 2-year progression along the Age-Related Eye Disease Study age-related macular degeneration (AREDS AMD) scale. Among 3,868 participants in the AREDS, statistically significant correlations were observed between at least 2-step and at least 3-step 2-year progression of AMD score (occurring between baseline and the 2-year study visit) and subsequent 5-year development of neovascular AMD, central geographic atrophy, any geographic atrophy, or best-corrected visual acuity loss. Findings support a possible utility of two-year progression of AMD score in determining the risk of late AMD outcomes and loss of visual acuity; this finding establishes the viability of the AREDS AMD scale in describing AMD progression.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay